Eli Lilly and Co said on Wednesday the U.S. government has purchased 650,000 additional doses of its COVID-19 antibody drug for $812.5 million.

Eli Lilly and Co on Wednesday said a single infusion of its experimental antibody treatment reduced the need for hospitalization and emergency room visits for clinical trial patients with moderate ...

The Elastomeric infusion pumps market grows with rising chronic diseases, home care demand, and innovations in biocompatible, sustainable drug delivery. BRENTFORD, ENGLAND, UNITED KINGDOM, October 7, ...

The U.S. Food and Drug Administration (FDA) has approved Lasix ONYU (furosemide injection), a new drug-device combination ...

Once-yearly infusions of rituximab are as effective as twice-yearly dosing for sustained control of MS in a new phase 3 trial ...

Australian researchers have discovered that an anti-inflammatory drug already being used to treat rheumatoid arthritis could ...

Low-dose IV infusions of ketamine are safe and effective in treating chronic pain, a new study says. Ketamine infusions as ...

Pharmaceutical companies argue the negotiation program, in which the government sets how much the federal health insurance ...

The Food and Drug Administration (FDA) has approved Libtayo (cemiplimab-rwlc) for the adjuvant, or postsurgical, treatment of ...

Becker's asked pharmacy executives from hospitals and health systems across the U.S. to share the most underappreciated trends in healthcare today. The ...